Volkswagen Teramont Debuts in Moscow with Limited-Time Offer

No time to read?
Get a summary

A major Moscow dealer has begun offering the Volkswagen Teramont crossover, according to a manager at the dealership. The arrival of this model is attributed to shipments from manufacturing partners in Asia, accompanied by a two-year factory warranty that speaks to the confidence behind the vehicle and its after-sales support.

The car is available at a price of 8 million rubles in the highest trim level when purchased with cash. The dealer signals substantial savings if buyers pursue financing or participate in a trade-in program, with potential reductions bringing the price down to around 7 million rubles. It is also noted that this quoted price is time-limited and will rise after February, prompting buyers to move quickly to secure the current deal.

Under the hood, the Teramont is powered by a 2.0-liter gasoline engine delivering about 220 horsepower, enabling a top speed near 200 km/h. In the top specification, buyers gain access to features such as climate control, cruise control, a rain sensor, a leather interior, heated seats throughout, and a suite of comfort and convenience options that enhance daily driving and longer journeys alike.

Historically, the German automaker Volkswagen halted operations in Russia in 2022, amid broader corporate realignment. By early 2023, market observers noted that Teramont crossovers reportedly delivered to the Moscow region had already sold out in the initial wave of domestic availability, reflecting strong demand for new models within the evolving market landscape.

In a separate note from the industry, Renault previously introduced an ambitious concept toward novelty in vehicle design, illustrating how automakers experiment with everyday utility in novel ways. This kind of experimentation underscores the ongoing evolution of product features and user expectations across the global auto industry.

No time to read?
Get a summary
Previous Article

Meta Title Variant 10

Next Article

{REWRITTEN}: City of Hope Develops Antibody to Target Leukemia Stem Cells